Clinical Trial Update: Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a gene transfer therapy for limb-girdle muscular dystrophy type 2D has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-girdle Muscular Dystrophy Type 2d

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Muscular Dystrophies | Phase 1 | Status: COMPLETED